Nifty Pharma index extends gaining spree; Dr Reddy's top gainer; Aurobindo, Divis Lab add to gains

Auro Pharma advanced 1.25% while Cadila and Divis Lab gained nearly 1% to lift sectorial performance.

Apr 07, 2021 12:04 IST India Infoline News Service

Nifty Pharma stocks continued to outperform amid progression in vaccine drives. The Index climbed over 1% to further lift the bullish indices.

Dr Reddy’s was the top gainer on the index while Auro Pharma and Divis Lab also surged over 1%. Cadila also stretched the winning streak.

The Covid-19 vaccination drive continues in full swing as cases continue to rise due second wave of the virus in India. More than 8.3 crore people vaccinated against Covid-19, according to Union Health Ministry.

Ata round 12.52 pm, Nifty Pharma was trading at 12,662.90 up 114.30 points or 0.91%, hitting a day’s high of 12,695.10 during intraday trade on Wednesday.

Dr Reddy's surged nearly 2.5% at Rs4,733.00 per piece. Auro Pharma advanced 1.25% at Rs904.00 per piece.

Cadila and Divis Lab gained nearly 1% at Rs460.95 per piece and Rs3,723.95 per piece respectively. 

Torrent Pharma was also up 0.75% and Sun Pharma also gained 0.51% to lift the sectorial performance. Cipla was also 0.41% higher.

Alkem Lab, Lupin and Biocon trade flat in an all green index. 

Related Story

Open Free Demat Account (Rs699)